Post-COVID-19 sequelae

COVID-19 is a new disease and the acute clinical presentation is mostly clear now. It is also known now that the disease may have sequelae affecting various systems. The respiratory sequelae include pulmonary fibrosis due to the immune-mediated mechanisms that follow a cytokine storm, diffuse alveol...

Full description

Bibliographic Details
Published in:	Indian Journal of Respiratory Care
Main Author:	Uthara Vijai Kumar
Format:	Article
Language:	English
Published:	Jaypee Brothers Medical Publisher 2021-01-01
Subjects:	covid-19-associated pulmonary aspergillosis post-covid-19 sequelae pulmonary fibrosis thromboembolic disease
Online Access:	http://www.ijrc.in/article.asp?issn=2277-9019;year=2021;volume=10;issue=4;spage=60;epage=63;aulast=Kumar

Similar Items

Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis
by: Xianglin Zhou, et al.
Published: (2022-06-01)

Pharmacological approaches to pulmonary fibrosis following COVID-19
by: Stefan Lassan, et al.
Published: (2023-06-01)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
by: Simon Feys, et al.
Published: (2021-12-01)

COVID-19 Associated Pulmonary Aspergillosis: A Case Series
by: Mira Yulianti, et al.
Published: (2022-07-01)

Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
by: Sy Duong-Quy, et al.
Published: (2023-05-01)

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
by: María Ruiz-Ruigómez, et al.
Published: (2022-08-01)

A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold
by: Tommaso Lupia, et al.
Published: (2022-11-01)

Surveying the aftermath: a qualitative and semiquantitative study of post-COVID-19 sequelae in the lungs
by: Kurian C. Eapen, et al.
Published: (2025-01-01)

Predictors of symptom persistence and respiratory sequelae in respiratory symptomatics presenting to a post-COVID clinic
by: Athulya S Kumar, et al.
Published: (2023-10-01)

COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece
by: Konstantinos Ouranos, et al.
Published: (2023-01-01)

Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
by: Tim Fischer, et al.
Published: (2022-05-01)

Are there pulmonary sequelae in patients recovering from COVID-19?
by: Paola Rogliani, et al.
Published: (2020-10-01)

Thymic Hyperplasia and COVID-19 Pulmonary Sequelae: A Bicentric CT-Based Follow-Up Study
by: Michaela Cellina, et al.
Published: (2024-05-01)

Longitudinal alterations of gut mycobiota during 2 years after COVID-19 and its correlation with pulmonary sequela
by: Qianhan Xie, et al.
Published: (2025-07-01)

Post-COVID pulmonary fungal infections: An unanticipated predicament or a ticking time bomb? Clinico-microbiological profile of cases encountered during the second wave of COVID-19 pandemic at a teaching hospital in the Himalayas with a brief literature review
by: Oshin Puri, et al.
Published: (2023-12-01)

Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis
by: Matsuo So, et al.
Published: (2021-03-01)

Four-year respiratory consequences of COVID-19 related pneumonia: a longitudinal cohort study
by: Saioa Eizaguirre, et al.
Published: (2025-07-01)

12-month risk factor evaluation for persistent pulmonary symptoms in long COVID-19 patients
by: Eman M. Emad Eldin, et al.
Published: (2024-02-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges
by: Aia Mohamed, et al.
Published: (2020-07-01)

Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis
by: Jeffrey D. Jenks, et al.
Published: (2024-06-01)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
by: Filippo Patrucco, et al.
Published: (2023-03-01)

Post-COVID-19 Fungal Infections: A Case Series
by: Rupak Chatterjee, et al.
Published: (2024-07-01)

Long-term respiratory consequences of COVID-19 related pneumonia: a cohort study
by: Saioa Eizaguirre, et al.
Published: (2023-11-01)

COVID-19-associated rhino-mucormycosis and pulmonary aspergillosis infection
by: Jitender Singh, et al.
Published: (2022-01-01)

Integrating CT radiomics and clinical features using machine learning to predict post-COVID pulmonary fibrosis
by: Qianqian Zhao, et al.
Published: (2025-07-01)

COVID-19-Associated Pulmonary Aspergillosis in Russia
by: Olga Shadrivova, et al.
Published: (2021-12-01)

Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
by: Janet Johnston, et al.
Published: (2023-09-01)

Computed tomography signs of the possible aspergillosis in the dynamic observation of patients with COVID-19
by: Myo Tun Nay, et al.
Published: (2024-04-01)

COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital
by: David Ranhel, et al.
Published: (2021-10-01)

Impact of COVID-19 on quality of life in survivors with pulmonary sequelae
by: Irene Rodríguez-Galán, et al.
Published: (2024-03-01)

Inpatient post-COVID-19 rehabilitation program featuring virtual reality—Preliminary results of randomized controlled trial
by: Sebastian Rutkowski, et al.
Published: (2023-02-01)

Post-acute sequelae of COVID-19 3 to 12 months after infection: Delta vs Omicron
by: Siméon de Bruijn, et al.
Published: (2025-01-01)

Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians
by: Giuseppe Fabio Parisi, et al.
Published: (2021-08-01)

Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients
by: Adeel Nasrullah, et al.
Published: (2024-05-01)

Post-COVID-19 cardio-pulmonary manifestations after 1-year of SARS-CoV-2 infection among Indian population: A single centre, case-control study (OneCoV2 study)
by: Sumit Rajotiya, et al.
Published: (2024-01-01)

COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
by: Pierre Bay, et al.
Published: (2024-04-01)

Influence of smoking and obesity on post-COVID-19 sequelae and risk of hospitalization
by: Daniel Fernández-Pedruelo, et al.
Published: (2024-12-01)

Association of thrombosis and mortality in patients with COVID-19 infections: a hospital-based observational study
by: Sher M. Sethi, et al.
Published: (2022-08-01)

Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report
by: Elahe Sasani, et al.
Published: (2024-06-01)